Aptose Biosciences (APTO) Soars After Robust Quarterly Earnings

The Aptose Biosciences (NASDAQ: APTO) stock has been one of the more eye-catching gainers during premarket trading this morning.

Aptose Biosciences (APTO) Soars After Robust Quarterly Earnings

The stock has gone up by as high as 32% this morning so far and it is a direct result of the announcement of the financial results from Aptose on Tuesday. The company announced its financial results for the full year 2020 and also for the quarter that ended on December 31, 2020.

Aptose suffered a net loss of as much as $14.7 million in the fourth quarter and that figure was considerably more than the $7.7 million that it had suffered in the year-ago period. On the other hand, the net losses for the full year came in at $55.2 million as opposed to $26.3 million in Q4 2019. At the end of the year, Aptose had cash, investments, and cash equivalents to the tune of $122.4 million. Investors could do well to keep an eye on the stock today.

Uson Abdilazhanov

Editor and Computer Expert A hardcore tech enthusiast and computer expert Uson Abdilazhanov who holds a degree in communications started writing in his personal blogs since 2012. That time he was interested in the technical part of the computer. But now the software aspect plays an important role in his career. Currently, he runs a PC building and repairing shop which helps a lot of designers and gamers who always like to try new things.